80 studies found for:    vaccine niaid | Open Studies
Show Display Options
Rank Status Study
1 Recruiting A Phase II, Open Label Trial of a Vaccine (FSME-IMMUN 0.5 mL Baxter) Against Tick-borne Encephalitis (TBE) for NIAID Workers Manipulating Tick Borne Encephalitis Virus (TBEV) in the Laboratory
Conditions: Tick-Borne Encephalitis;   Encephalitis, Tick-Borne;   Tick-Borne Disease;   Glycoprotein E, Flavivirus;   NSI Protein, Flavivirus
Intervention: Biological: FSME-IMMUN 0.5ml Baxter
2 Recruiting Therapeutic Vaccine for HIV
Conditions: HIV;   Therapeutic Vaccine
Interventions: Biological: rVSV;   Biological: IL-12 pDNA adjuvant;   Biological: HIV-Mag pDNA
3 Recruiting Screening of Volunteers for Clinical Trials of Investigational or Licensed Vaccines or Antiviral Products
Condition: Healthy Volunteers
Intervention:
4 Recruiting Screening Volunteers for Clinical Trials
Condition: Human Volunteers
Intervention:
5 Recruiting Volunteer Screening for Vaccine and Antivirals Clinical Trials
Condition: Healthy Volunteer
Intervention:
6 Recruiting Study of the Safety of a Particular Herpes Vaccine in Adults With or Without Herpes Infection
Conditions: Genital Herpes;   Herpes Simplex Virus;   Herpes Simplex Virus Vaccines;   HSV Vaccines;   Herpesvirus Vaccines
Intervention: Biological: HSV529
7 Recruiting Experimental AD4-H5-VTN Vaccine in Healthy Volunteers
Condition: H5N1 Influenza
Interventions: Biological: Ad4-H5-VTN vaccination-tonsillar route;   Biological: Ad4-H5-vaccination-oral route
8 Recruiting Study of Safety and Immunogenicity of HIV Vaccines in Healthy Volunteers
Conditions: Healthy Volunteer;   HIV Vaccine
Interventions: Biological: Ad4-mgag;   Biological: Ad4-EnvC150
9 Recruiting Study of Controlled Human Malaria Infections to Evaluate Protection After Intravenous or Intramuscular Administration of PfSPZ Vaccine in Malaria-Naive Adults
Conditions: Malaria;   Prevention and Control;   Acquired Immunity;   Parasitemia
Intervention: Biological: PfSPZ
10 Recruiting Safety, Tolerability, and Immunogenicity of the Ebola Chimpanzee Adenovirus Vector Vaccine (cAd3-EBO), VRC-EBOADC069-00-VP, in Healthy Adults
Condition: Healthy Adult Immune Responses to Vaccine
Intervention: Biological: VRC-EBOADC069-00-VP
11 Recruiting Intranasal AD4-H5-VTN as an Adenovirus Vaccine
Condition: Healthy Volunteer
Intervention: Biological: Ad4-H5-Vtn
12 Recruiting H7 Influenza Prime-Boost Regimens in Healthy Adults: Recombinant H7 DNA Plasmid Vaccine, VRC-FLUDNA071-00-VP, Administered Alone or With Monovalent Influenza Subunit Virion H7N9 Vaccine (MIV) as Prime With MIV Boost Compared to MIV Prime With MIV Boo...
Condition: Influenza
Interventions: Biological: A/Shanghai/02/2013 (H7N9) MIV;   Biological: VRC-FLUDNA071-00-VP
13 Recruiting Antibody Production in Immune Disorders
Condition: Immunologic Disease
Intervention:
14 Recruiting Apheresis and Specimen Collection Procedures to Obtain Plasma, Peripheral Blood Mononuclear Cells (PBMCs) and Other Specimens for Research Studies
Condition: Blood Component Removal
Intervention:
15 Recruiting VRC 900: Evaluation of Tissue-Specific Immune Responses in Adults 18 Years of Age and Older
Conditions: Immunity, Mucosal;   Immune System Processes;   Blood Specimen Collection
Intervention:
16 Not yet recruiting Evaluating the Safety and Immune Response to Three Different Prime-Boost HIV Vaccine Regimens in Healthy, HIV-Uninfected Adults
Condition: HIV Infections
Interventions: Biological: DNA Nat-B env vaccine;   Biological: NYVAC Nat-B env vaccine;   Biological: DNA CON-S env vaccine;   Biological: NYVAC CON-S env vaccine;   Biological: DNA Mosaic env vaccine;   Biological: NYVAC Mosaic env vaccine;   Biological: Placebo;   Device: Biojector 2000® Needle-Free Injection Management System™ (Biojector 2000®)
17 Recruiting Evaluating the Safety and Immune Response to Two Admixtures of a Tetravalent Dengue Virus Vaccine
Condition: Dengue
Interventions: Biological: TetraVax-DV Vaccine - Admixture TV003;   Biological: TetraVax-DV Vaccine - Admixture TV005;   Biological: Placebo
18 Recruiting A Phase IIb, Open-Label, Dose Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine
Condition: Pneumococcal Infection
Intervention: Biological: Prevnar 13 (PVC13)
19 Not yet recruiting A Phase I Study Priming With an Inactivated A/H7N9 Influenza Virus Vaccine With or Without MF59 Adjuvant Followed by Live Attenuated A/H7N9 Influenza Virus Vaccine
Condition: Avian Influenza
Interventions: Drug: MF59 Adjuvant;   Biological: A/H7N9 pIIV Vaccine;   Biological: H7N9 pLAIV Vaccine
20 Recruiting Safety of a Live Attenuated Human Parainfluenza Virus Type 2 (HPIV2) Vaccine for Adults, Children, and Infants
Condition: Human Parainfluenza Virus 2
Interventions: Biological: Standard Dose HPIV2 Vaccine;   Biological: Low dose HPIV2 vaccine;   Other: Placebo

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years